BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3125990)

  • 1. [Effect of hydralazine on the pulmonary arterial hypertension in monocrotaline induced cor pulmonale in Macacus rhesus].
    Sun BT
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Aug; 10(4):229-30, 255, 15. PubMed ID: 3125990
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monocrotaline-induced cor pulmonale in the rhesus monkey: ultrastructural changes of lung and heart].
    Sun BT
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Apr; 10(3):148-51, 191, 11-2. PubMed ID: 3130198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pulmonary circulatory disturbance due to pulmonary peripheral lesions--etiology of experimental pulmonary hypertension and cor pulmonale].
    Watanabe S
    Kokyu To Junkan; 1981 May; 29(5):481-5. PubMed ID: 6797009
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
    Lalich JL; Johnson WD; Raczniak TJ; Shumaker RC
    Arch Pathol Lab Med; 1977 Feb; 101(2):69-73. PubMed ID: 138406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D; Reid LM
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocardial fibrosis associated with monocrotaline-induced pulmonary hypertension in nonhuman primates (Macaca arctoides).
    Chesney CF; Allen JR
    Am J Vet Res; 1973 Dec; 34(12):1577-81. PubMed ID: 4271643
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
    Kasian GF; Ninan A; Duncan WJ; Bingham WT; Mersal A; Tyrrell MJ; Sankaran K
    Can J Cardiol; 1988 May; 4(4):181-4. PubMed ID: 3395914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U; Olson JW; Gillespie MN
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of the development of pulmonary hypertension induced by monocrotaline in rats].
    Kataoka R; Tobise K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 May; 25(5):563-73. PubMed ID: 3118089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reduction of the development of monocrotaline-induced pulmonary hypertension in rats by artificial unilateral pneumothorax].
    Sugita T; Sawada A; Kuriyama T; Yamagishi F; Kohchi F; Naitoh T; Kakusaka I; Okada O; Watanabe S; Ogata T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1328-36. PubMed ID: 3937926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
    Kuriyama T; Sawada A; Sugita T; Watanabe S; Shen SY; Hiroshima K; Hayashi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):865-72. PubMed ID: 3935842
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E; Seoane M; Verdejo J; Gomez A; Sandoval J; Barrios R; Martinez W
    Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological study on monocrotaline-induced pulmonary hypertension in rats (author's transl].
    Kido M
    Fukuoka Igaku Zasshi; 1981 Mar; 72(3):117-30. PubMed ID: 6790398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monocrotaline-induced pulmonary hypertension with special reference to the influence of dose, age, and sex].
    Sawada A; Kuriyama T; Sugita T; Watanabe S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):578-83. PubMed ID: 3932735
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrastructure of the right ventricle after monocrotaline-induced cor pulmonale in the nonhuman primate (Macaca arctoides).
    Raczniak TJ; Chesney CF; Allen JR
    Exp Mol Pathol; 1978 Feb; 28(1):107-18. PubMed ID: 413738
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental study on monocrotaline induced pulmonary hypertensive rats. (1) Effect of long-term injection of immunosuppressant.
    Tanabe T; Furuya H; Kanemoto N; Goto Y; Hata J
    Tokai J Exp Clin Med; 1981 Jan; 6(1):41-8. PubMed ID: 6789505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
    Nakashima M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar; 21(3):227-39. PubMed ID: 6415328
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic principles in pulmonary hypertension and cor pulmonale].
    Kohl FV
    Internist (Berl); 1988 Oct; 29(10):688-96. PubMed ID: 3069780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.